Conferences - Results from #9720

Viewing 9721-9740 of 11775 articles

ASCO GU 2017: Actionable targets in germ cell tumors - Session Highlights

ASCO GU 2017: Best of Journals: Renal Cell Carcinoma – Urologic Oncology - Session Highlights

ASCO GU 2017: Best of journals: Renal Cell Carcinoma - Radiologist - Session Highlights

ASCO GU 2017: Quality of care in non-muscle invasive bladder cancer: optimizing surgical and medical therapies - Session Highlights

ASCO GU 2017: Intravesical rAD-IFNa/Syn3 for patients with high-grade, Bacillus Calmette-Guerin (BCG) refractory or relapsed non-muscle invasive bladder cancer: a phase II randomized study - Session Highlights

ASCO GU 2017: Options for the Patient Who Does Not Respond to Bacillus Calmette-Guérin When Radical Cystectomy Is Not an Option - Session Highlights

ASCO GU 2017: Barriers in Progress in Muscle-Invasive and Non-muscle Invasive Bladder Cancer - Oncology Perspective - Session Highlights

ASCO GU 2017: Barriers in Progress in Muscle-Invasive and Non-muscle Invasive Bladder Cancer - Urology Perspective - Session Highlights

ASCO GU 2017: Barriers in Progress in Muscle-Invasive and Non-muscle Invasive Bladder Cancer - Session Highlights

ASCO GU 2017: Keynote Lecture: Testicular Cancer - Session Highlights

ASCO GU 2017: Year in Review: Penile Cancer - Session Highlights

ASCO GU 2017: Urothelial Carcinoma: Year in Review - Session Highlights

ASCO GU 2017: Keynote Lecture, Emerging Impact of Genomics on the Clinical Management of Bladder Cancer - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Urologist View - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Medical Oncologist’s Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Surgeon’s Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Urologist Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Radiation Oncology Perspective - Session Highlights

ASCO GU 2017: Optimizing Outcomes in Muscle-Invasive and Metastatic Bladder Cancer - Session Highlights

ASCO GU 2017: Best of Journals: Prostate Cancer - Medical Oncologist Perspective - Session Highlights

482
483
484
485
486
487
488
489
490
491